Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Vericiguat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,723Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Alliance revenue - Adempas/Verquvo

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Alliance revenue - Adempas/Verquvo

    Vericiguat

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Alliance revenue - Adempas/Verquvo

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Merck & Co.

    Vericiguat

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 341

    2021 Revenue in Millions : 342

    Growth (%) : -0.3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Alliance revenue - Adempas/Verquvo

    Vericiguat

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Alliance revenue - Adempas/Verquvo

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Merck & Co.

    Vericiguat

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 367

    2022 Revenue in Millions : 341

    Growth (%) : 7.6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Alliance revenue - Adempas/Verquvo

    Riociguat, Vericiguat

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Alliance revenue - Adempas/Verquvo

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Merck & Co.

    Riociguat, Vericiguat

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2024 Revenue in Millions : 415

    2023 Revenue in Millions : 367

    Growth (%) : 13.1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF